Advertisement

Rare skeletal muscle metastasis from renal cell carcinoma: case report and review of the literature

  • Rida Salman
  • Mikhael G. Sebaaly
  • Karl Asmar
  • Mohammad Nasserdine
  • Sami Bannoura
  • Nabil J. Khoury
Case Report

Abstract

Renal cell carcinoma (RCC) is a tumor that usually metastasizes to lung, liver, bone and brain, but rarely to skeletal muscles. We report a case of an elderly man with a history of bilateral metachronous RCC for which he underwent curative bilateral nephrectomies and renal transplantation, was in remission, and presented with a large solitary skeletal muscle metastasis from the initial RCC, 3 years later.

Keywords

Renal cell carcinoma Skeletal muscle metastasis 

Notes

Compliance with ethical standards

Conflict of interest

All the authors have declared no competing interest.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Research involving human participants and/or animals

This article does not contain any studies with human participants performed by any of the authors.

References

  1. 1.
    Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56(2):106–30.CrossRefPubMedGoogle Scholar
  2. 2.
    Ghosn M, Jaloudi M, Larbaoui B. Insights into the epidemiology of renal cell carcinoma in North Africa and the Middle East. Pan Arab J Oncol. 2005;8(2):38–43.Google Scholar
  3. 3.
    Surov A, Hainz M, Holzhausen HJ, Arnold D, Katzer M, Schmidt J, et al. Skeletal muscle metastases: primary tumours, prevalence, and radiological features. Eur Radiol. 2010;20(3):649–58.CrossRefPubMedGoogle Scholar
  4. 4.
    Molina-Garrido MJ, Guillen-Ponce C. Muscle metastasis of carcinoma. Clin Transl Oncol. 2011;13(2):98–101.CrossRefPubMedGoogle Scholar
  5. 5.
    Damron TA, Heiner J. Distant soft tissue metastases: a series of 30 new patients and 91 cases from the literature. Ann Surg Oncol. 2000;7(7):526–34.CrossRefPubMedGoogle Scholar
  6. 6.
    Surov A, Köhler J, Wienke A, Gufler H, Bach AG, Schramm D, et al. Muscle metastases: comparison of features in different primary tumours. Cancer Imaging. 2014;14(1):21.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Pirimoglu B, Ogul H, Kisaoglu A, Karaca L, Okur A, Kantarci M. Multiple muscle metastases of the renal cell carcinoma after radical nephrectomy. Int Surg. 2015;100(4):761–4.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Tremblay F, Fernandes M, Habbab F, de Edwardes MDB, Loertscher R, Meterissian S. Malignancy after renal transplantation: incidence and role of type of immunosuppression. Ann Surg Oncol. 2002;9(8):785–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Agraharkar ML, Cinclair RD, Kuo YF, Daller JA, Shahinian VB. Risk of malignancy with long-term immunosuppression in renal transplant recipients. Kidney Int. 2004;66(1):383–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Lim WH, Russ GR, Wong G, Pilmore H, Kanellis J, Chadban SJ. The risk of cancer in kidney transplant recipients may be reduced in those maintained on everolimus and reduced cyclosporine. Kidney Int. 2017;91(4):954–63.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2018

Authors and Affiliations

  • Rida Salman
    • 1
  • Mikhael G. Sebaaly
    • 1
  • Karl Asmar
    • 1
  • Mohammad Nasserdine
    • 2
  • Sami Bannoura
    • 3
  • Nabil J. Khoury
    • 1
  1. 1.Diagnostic Radiology DepartmentAmerican University of Beirut Medical CenterBeirutLebanon
  2. 2.Division of Orthopedic Surgery, Department of SurgeryAmerican University of Beirut Medical CenterBeirutLebanon
  3. 3.Department of Pathology and Laboratory MedicineAmerican University of Beirut Medical CenterBeirutLebanon

Personalised recommendations